After prematurely ending two phase 3 depression trials last year, Relmada Therapeutics has formally given up on the asset ...

Major depressive disorder (MDD) is a common mood disorder characterized by persistent sadness and a loss of interest in activities, impacting mood, behavior, and physical functions. Symptoms of ...

Although transcranial electrical stimulation is linked to reduced depressive symptoms, the effect varies by brain stim type ...

Young adults with major depressive disorder show distinct metabolic signals in two brain regions, and the pattern differs between those who struggle on thinking tasks and those who do not. In a new ...

Standardized screening tools such as Major Depression Inventory can be used to detect major depressive disorder. The most common time of onset is between the ages of 20 and 30 years, with a later ...

A phase 2 trial shows that a single dose of psilocybin provides lasting relief from symptoms of depression and anxiety. New ...